T. Rowe Price Associates »

Spyglass Pharma shares owned by T. Rowe Price Associates

Quarter-by-quarter ownership of Spyglass Pharma (SGP) shares owned by T. Rowe Price Associates from 13F filings

Historical chart of T. Rowe Price Associates investment in Spyglass Pharma

Tip: Access up to 7 years of quarterly data

All positions including Spyglass Pharma held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Spyglass Pharma by T. Rowe Price Associates

Quarter filed Position value Share count Share price at filing
2026-03-31 $18M 704k 25.94

More positions owned by T. Rowe Price Associates

Nvidia Corporation Comm Stk (NVDA)
Apple Comm Stk (AAPL)
Microsoft Corp Comm Stk (MSFT)
Broadcom Comm Stk (AVGO)
Amazon Comm Stk (AMZN)
Alphabet Comm Stk (GOOGL)
Alphabet Comm Stk (GOOG)
Meta Platforms Comm Stk (META)
Eli Lilly & Co Comm Stk (LLY)
Visa Comm Stk (V)
Netflix Comm Stk (NFLX)
Mastercard Incorporated Comm Stk (MA)
Tesla Comm Stk (TSLA)
Jpmorgan Chase & Co Comm Stk (JPM)
Ge Aerospace Comm Stk (GE)

View all positions for T. Rowe Price Associates

Top funds holding Spyglass Pharma

RA Capital Management
NEA Management Company
Sands Capital Ventures
Samsara BioCapital
BlackRock
T. Rowe Price Associates
Vestal Point Capital
Jpmorgan Chase & Co
Deerfield Management Company
Millennium Management
Standard Life Aberdeen
Vanguard Capital Management
Geode Capital Management
Franklin Resources
Affinity Asset Advisors

View all funds holding Spyglass Pharma